Skip to main content

MoneyWorks4Me

Nectar Lifesciences informs about post buyback public announcement

16 Jan 2026 Evaluate
Nectar Lifesciences has informed that Master Capital Services (Manager to the Buyback) has submitted a copy of Post Buyback Public Announcement for the attention of equity shareholders / beneficial owners of equity shares of Nectar Lifesciences (the Company).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..